Page 2 - J&j

Johnson & Johnson says Covid-19 booster shot is 94% effective

J&J said a booster given two months after the first dose increased antibody levels four to six-fold

J&J says coronavirus vaccine booster shot triggered an antibody surge

ignificant increases in antibody responses were seen in subjects ages 18 to 55 years old, and among those 65 or older who were given a lower dose of the booster.

Joaquin Duato set to replace Alex Gorsky as Johnson & Johnson's CEO

Duato, 59, currently serves as vice chairman of J&J's executive committee

India Coronavirus Dispatch: 2 in 5 districts yet to get RT-PCR testing lab

No clarity on the launch of single-dose J&J vaccine, over 60% doses given to rural population in last 3 weeks, and more-news relevant to India's fight against the pandemic

J&J seeks approval for single-dose Covid-19 vaccine in India

It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers

J&J says still in talks with Indian govt on Covid-19 vaccine

India had, in May, scrapped local trials for 'well-established' foreign coronavirus vaccines as it tried to hasten vaccination rollouts to fight a second wave of infections.

In talks with Pfizer, Moderna, J&J to make vaccines in India: Foreign secy

India is looking forward to WHO's nod for vaccine manufactured by Bharat Biotech

Covid-19 vaccination: Germany allows J&J, AstraZeneca jabs for all adults

Germany is making the one-shot Johnson & Johnson coronavirus vaccine available to all adults as it did with the AstraZeneca vaccine, though the bulk of the expected deliveries is still some way off. Germany has recommended the AstraZeneca shot mainly for over-60s because of a rare type of blood clot seen in an extremely small number of recipients. But amid a push to get as many people inoculated as possible, the government decided to allow doctors' offices to vaccinate any adults with it -- putting aside a priority system under which the oldest and most vulnerable have been vaccinated first. Health Minister Jens Spahn said authorities decided Monday to take the same approach with the Johnson & Johnson vaccine, about which there are similar concerns. He estimated that 5 to 6 million over-60s in Germany still need to be vaccinated and that should be concluded by early June. Spahn said the largest deliveries from Johnson & Johnson, more than 10 million doses, are expected in .

30 year old man in US hospitalised with clot after receiving J&J vaccine

A San Francisco Bay Area man in his 30s is recuperating after developing a rare blood clot in his leg within two weeks of receiving the Johnson & Johnson vaccine, University of California, San Francisco officials said. As of Friday, the US Centers for Disease Control and Prevention had reported the condition in 15 people, all women, after 8 million doses were administered nationally. It involves unusual clots that occur together with low levels of blood-clotting platelets. To the best of our knowledge, this is the first male patient with VITT syndrome in the US following the US emergency authorization of the Johnson & Johnson vaccine on February 27, 2021," UCSF said in a statement. US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot on Friday, after scientific advisers decided its benefits outweigh the rare risk of blood clot. Three of the women previously identified died, and seven remain hospitalised. The man is .

J&J to resume rollout of Covid-19 vaccine in Europe with safety warning

(Reuters) -Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region's medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.

J&J, other drugmakers go to trial in US in $50 bn case over opioid abuse

J&J, Teva Pharmaceutical Industries Ltd, Endo International Plc and AbbVie's Allergan unit are alleged of fueling a drug crisis that according to the US government resulted in nearly 500,00 deaths

After US, South Africa suspends use of Johnson & Johnson Covid-19 vaccine

South African Health Minister Zweli Mkhize on Tuesday said that the country will be suspending the use of the Johnson & Johnson COVID-19 vaccine after health concerns raised by the US Food and Drug Administration (FDA)."We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson and Johnson vaccine is sufficiently interrogated," Mkhize said in a statement."In the extremely unlikely event that Johnson and Johnson rollout is completely halted, we will not have any impediment to proceed with phase two of the rollout with Pfizer," he added.This comes after the US Centers of Disease Control and Prevention (CDC) and the FDA recommended a "pause" in the use of the Johnson and Johnson COVID-19 vaccine "out of an abundance of caution" over six reported cases in the US of a "rare and severe" type of blood clot.In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after .

Top headlines: India fast-tracks approval for vaccines; Bitcoin near $63k

From govt fast-tracking approval for foreign-produced Covid vaccines to JLR reporting over 12% rise in Q4 retail sales, here are top headlines this evening.

Johnson & Johnson CEO pay irks investors upset with opioid lawsuits fallout

(Reuters) - Johnson & Johnson is coming under fire from some investors who are raising questions about companies that give their chief executives hefty pay raises despite facing billions of dollars in legal costs over their role in the U.S. opioid crisis.

Biden plans to order 100 million more J&J coronavirus vaccine doses

US President Joe Biden has said that his administration will order another 100 million doses of the Johnson & Johnson Covid-19 vaccine.

J&J applies to WHO for emergency use listing of Covid-19 vaccine

J&J said an emergency use listing is a prerequisite for supplying vaccines to the COVAX vaccine program, co-led by WHO, which aims to deliver doses to poor and middle-income countries

J&J's vaccine implementation study in South Africa gets regulator nod

South Africa has yet to launch its Covid-19 vaccination programme and the government has decided to go with the J&J dose

UK, EU nations rally behind Astra jab after South Africa halts roll-out

South Africa looks to J&J vaccine

J&J confirms pausing Covid-19 vaccine trial because of unexplained illness

Earlier this month, Johnson & Johnson joined the short list of vaccine makers that have moved an experimental coronavirus shot into late-stage human studies

Some volunteers quit J&J Covid-19 trial in Spain after AstraZeneca scare

MADRID (Reuters) - Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.